u/Jackrabbit099 · 378d agono track record yet
FEMY (Femasys Inc.) – FDA Catalyst + Short Squeeze + Long-Term Growth Play
Femasys (FEMY) is a low-float, highly shorted ($28.5M market cap, 57% short ratio) small-cap med-tech that just received FDA approval to advance its FemBloc permanent birth control device into final trials. The combination of short-squeeze potential from high short volume and long-term upside from a tangible FDA-backed product pipeline addressing unmet women's health demand creates bullish setup for near-term momentum and potential multi-bagger valuation if trials progress.
At post $13.68Now $1.28-90.6% since postedas of Nov 16, 4:55 PM ET
1d+22.1%
3d+52.0%
1w+37.6%
1m+31.6%
3m-24.6%
6m-43.9%
1y-89.5%